SCHEMBL30140353

SCHEMBL30140353

Fc1cc2ncnc(Nc3ccc(OCC4CC4)c(Cl)c3F)c2nc1O[C@H]1CCNC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 14/20 0.44
FLT1 P17948 9/20 0.44
EGFR P00533 9/20 0.44
FGFR1 P11362 4/20 0.44
FLT4 P35916 4/20 0.44
EPHA2 P29317 11/20 0.42
EPHB4 P54760 9/20 0.42
ERBB2 P04626 6/20 0.39
RET P07949 2/20 0.38
GAK O14976 1/20 0.38
EPHB6 O15197 1/20 0.38
RIPK2 O43353 1/20 0.38
STK10 O94804 1/20 0.38
MAP4K4 O95819 1/20 0.38
ABL1 P00519 1/20 0.38
LCK P06239 1/20 0.38
YES1 P07947 1/20 0.38
LYN P07948 1/20 0.38
HCK P08631 1/20 0.38
BCR P11274 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30140412 0.93 KDR (0.43) KDRFLT1EGFRFGFR1FLT4
SCHEMBL30140272 0.88 EGFR (0.37) KDRFLT1EGFRFGFR1FLT4
SCHEMBL30140107 0.87 EGFR (0.39) KDRFLT1EGFRFGFR1FLT4
SCHEMBL30140375 0.87 GPR119 (0.38) KDRFLT1EGFRFGFR1FLT4
SCHEMBL30140217 0.86 KDR (0.41) KDRFLT1EGFRFGFR1FLT4
SCHEMBL30140366 0.86 GPR119 (0.37) KDRFLT1EGFRFGFR1FLT4
SCHEMBL30140239 0.85 EGFR (0.42) KDRFLT1EGFRFGFR1FLT4
SCHEMBL30140210 0.85 EGFR (0.42) KDRFLT1EGFRFGFR1FLT4
SCHEMBL23538163 0.84 EGFR (0.45) KDRFLT1EGFREPHA2EPHB4
SCHEMBL23538160 0.84 EGFR (0.45) KDRFLT1EGFREPHA2EPHB4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022266426-A1 6-(HETEROCYCLOALKYL-OXY)-QUINAZOLINE DERIVATIVES AND USES THEREOF BLACK DIAMOND THERAPEUTICS, INC. (US) 2022-12-22 WO disclosed